Suppr超能文献

糖尿病作为胰腺癌的一个风险因素:一项荟萃分析。

Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis.

作者信息

Everhart J, Wright D

机构信息

Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Md 20892-6600, USA.

出版信息

JAMA. 1995;273(20):1605-9.

PMID:7745774
Abstract

OBJECTIVE

To evaluate diabetes mellitus as a risk factor for pancreatic cancer with the consideration that diabetes may also be a consequence of pancreatic cancer.

DATA SOURCES

Pertinent studies of diabetes mellitus and pancreatic cancer published between 1975 and 1994 were identified from a MEDLINE search and from citations in articles and books.

STUDY SELECTION

Twenty of a total of 30 case-control and cohort studies met the two inclusion criteria: cases with a duration of diabetes of at least 1 year prior to either pancreatic cancer diagnosis or death and the ability to calculate an appropriate relative risk (RR) estimate and variance.

DATA EXTRACTION AND SYNTHESIS

The pooled RR and 95% confidence interval (CI) of pancreatic cancer for diabetics relative to nondiabetics was 2.1 (1.6 to 2.8). There was a tendency for a higher RR for the nine cohort studies (RR, 2.6; 95% CI, 1.6 to 4.1) than for the 11 case-control studies (RR, 1.8; 95% CI, 1.1 to 2.7). Requiring diabetes duration of at least 5 years resulted in an RR of 2.0 (95% CI, 1.2 to 3.2).

CONCLUSION

Pancreatic cancer occurs with increased frequency among persons with long-standing diabetes.

摘要

目的

鉴于糖尿病可能也是胰腺癌的一种后果,评估糖尿病作为胰腺癌危险因素的情况。

数据来源

通过医学文献数据库检索以及文章和书籍中的参考文献,确定了1975年至1994年间发表的关于糖尿病和胰腺癌的相关研究。

研究选择

总共30项病例对照研究和队列研究中的20项符合两项纳入标准:在胰腺癌诊断或死亡前糖尿病病程至少1年,并且能够计算适当的相对风险(RR)估计值和方差。

数据提取与综合分析

糖尿病患者患胰腺癌的合并RR及95%置信区间(CI)为2.1(1.6至2.8)。9项队列研究的RR(RR为2.6;95%CI为1.6至4.1)有高于11项病例对照研究(RR为1.8;95%CI为1.1至2.7)的趋势。要求糖尿病病程至少5年时,RR为2.0(95%CI为1.2至3.2)。

结论

长期糖尿病患者中胰腺癌的发生频率增加。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验